Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine Open-label Extension in Parkinson's Disease
NCT00519532Phase 3Terminated
- Sponsor
- UCB
- Start
- Jul 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of rotigotine in Parkinson's disease (PD), sponsored by UCB. Started Jul 2007; status: terminated.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00519532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519532.